Quarterly report [Sections 13 or 15(d)]

Revenue

v3.26.1
Revenue
 3 Months Ended
Mar. 31, 2026
Revenue Recognition [Abstract]  
Revenue Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
  Three Months Ended
March 31,
  2026 2025
 
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products $ 673  2.0  % $ 638  1.8  %
Third-Party Payer products 4,868  14.5  % 3,951  11.4  %
Patient Services revenue recognized over time:
Direct rental services 1,963  5.8  % 1,914  5.5  %
Third-Party Payer rental services 12,484  37.1  % 12,215  35.2  %
Total Patient Services accounted for under ASC 606 19,988  59.3  % 18,718  53.9  %
Device Solutions revenue recognized at a point in time:
Products 3,335  9.9  % 4,002  11.5  %
Services
 2,792  8.3  % 2,350  6.8  %
Device Solutions revenue recognized over time:
Services
 149  0.4  % 1,855  5.3  %
Total Device Solutions accounted for under ASC 606 6,276  18.6  % 8,207  23.6  %
Total Revenue Accounted for under ASC 606 26,264  78.0  % 26,925  77.6  %
Patient Services lease revenue
 2,117  6.3  % 2,056  5.9  %
Device Solutions lease revenue
 5,303  15.7  % 5,735  16.5  %
Total Revenue accounted for under ASC 842, Leases 7,420  22.0  % 7,791  22.4  %
Total Net Revenue $ 33,684  100.0  % $ 34,716 100.0  %
Contract Balances
(dollars in thousands)
As of March 31, 2026
As of December 31, 2025
 $ Change
Accounts receivable, net $ 23,980  $ 22,901  $ 1,079 
Contract assets $ 1,222  $ 1,244  $ (22)
Contract liabilities $ 156  $ 109  $ 47 
The change in contract assets during the three months ended March 31, 2026 included $0.9 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was partially offset by $0.9 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets. As of December 31, 2024, accounts receivable, net, and contract assets were $21.2 million and $0.6 million, respectively. As of December 31, 2024, there were no contract liabilities. Revenue recognized during the three months ended March 31, 2026 that was included in the contract liabilities at the beginning of the period was $0.1 million. The allowance for credit losses was $0.3 million as of both March 31, 2026 and December 31, 2025.